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Dr J. William Gaynor (Philadelphia, Pa). I’d like to congrat-
ulate Ms Lee and her coauthors on an excellent study, a wonderful
presentation, and thank them for sharing their manuscript with me.
This is a very timely topic. Obviously, as early outcomes for
congenital heart defects improve, follow-up with the later out-
comes becomes critically important. And this demonstrates that
even simple lesions, such as coarctation, which many people think
are fixed—in some studies none of these patients are even followed
by their cardiologist—have an alarming incidence of problems. I
have a couple of questions concerning this.
First, you found by echo a significant incidence of reobstruction,
and in the manuscript this is attributed to the hypoplastic arches.
Can you tellme from the echoeswherewas the level of obstruction?
Was it in the proximal arch or was it at the coarctation site itself?
Dr d’Udekem. There were 20 patients who had reobstruction
on echo. Their obstruction was defined on the basis of a flow accel-
eration into the descending aorta, and the gradient was superior to
25 mm Hg. They could not determine by the flow acceleration the
site of the obstruction. However, if you look at the measurements
of the aortic arch on echocardiogram, there were 5 patients who
had a segment of transverse arch that had a z score of<2: 1 patient
in the proximal arch, 2 patients in the distal arch, and 2 patients in
the isthmus. And, interestingly, if you compare this size with the
descending aorta, they would be all considered normal. Interest-
ingly, there was a significant difference in the size of the descend-
ing aorta between the patients with hypertension and those
without. I cannot explain that, but the hypertensive ones have
a smaller descending aorta.
When you look at the absolute number, the transverse arch
seems to be tapering down so that the size of the proximal arch
is between 1 cm and 2 cm, but more around the 1.5-cm mark,
and it goes a little bit smaller onto the distal transverse arch and,
again, a touch smaller on the isthmus. So it doesn’t fit the criteria
for obstruction strictly, but it seems to be tapering down, whichgery c November 2012
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ally good, because maybe having just a slightly smaller aorta is
enough to generate hypertension.
Dr Gaynor. And sort of along those lines, did you look at the
postoperative echoes? Do you know that there was adequate relief
of the obstruction at the time of the initial repair? Are we seeing
recurrent obstruction in these patients or residual obstruction? Be-
cause if you still have residual obstruction, it may affect the flow in
the arch.
Dr d’Udekem.We don’t have these results. But you have to re-
member that only half of those who were hypertensive in the long
term had reobstruction. So the way we define obstruction is not
able to identify the patients who develop hypertension in the
long term. And we suspect that having a small transverse arch is
a factor that promotes the genesis of hypertension. It may not be
the only one, as has been noted in the literature.
Dr Gaynor. I also think it’s important to look at the growth
characteristics. I mean, you state that the proximal arch didn’t
grow; however, the average z score was 2.43 before surgery,
and at the time of your last follow-up only 3 patients had a z score
<2. By definition, those are within the normal range. So there was
growth.
And along those lines, you don’t discuss it really here or in the
manuscript, you had a sizable subgroup of patients who had sub-
clavian flap aortoplasties. With that repair, nothing is done to ad-
dress the arch. Yet that did not appear to come out in your
analysis as a risk factor for reobstruction. So there is evidence
from some studies that the proximal arch may grow after a subcla-
vian flap. So I don’t know how to put these pieces of information
together.
I’m concerned that it may not be obstruction. There was only 1
patient with a blood pressure gradient, and the degree of obstruc-
tion is fairly mild. I’m not sure that we can attribute the hyperten-
sion to either the small arch or reobstruction. I’m more concerned
this is an intrinsic abnormality of the aorta. We know that the en-
dothelial function in the precoarctation bed remains abnormal
even after a successful neonatal repair. And, more important, the
aortic wall is very noncompliant. So this may not have anything
to do with reobstruction or a small arch. It may just be an intrinsic
characteristic of the aorta, which would explain why you don’t find
a relationship between the degree of obstruction and the degree of
hypertension.
Dr d’Udekem. I think the questions of how much the size, the
physical size of the arch, and how much these neurohumoral fac-
tors account for the development of hypertension remains open.
It’s difficult to sort out these issues and we keep working on this
topic.
We demonstrated in a previous publication that the statement
that the proximal transverse arch would grow if you restored nor-
mal antegrade flow after coarctation repair does not always stand
true, but not to the point that it would give you a proximal trans-
verse arch with a z score of3 or4. If you look at the data, the
arches do grow in some instance, but not reliably, not all of
them. And that’s why we were still doing subclavian flap repair
at the time.
Dr Gaynor. But in the table in your paper, the incidence of hy-
pertension at the subclavian flap was less than after the extended
end-to-end repair and basically the same as for your overallThe Journal of Thoracic and Carsternotomy group. So I think it’s important to realize that in
some patients you didn’t address the arch and those did not have
a higher incidence.
And we have seen anecdotally, we see these kids who have had
coarctation repairs and then come in with some mild obstruction.
They always tend to be athletes who get very hypertensive during
exercise. We relieve the obstruction either with a balloon or sur-
gery. They still have hypertension after exercise, suggesting,
again, it’s intrinsic aortic wall, not the obstruction.
Dr d’Udekem. There are 2 things. When you look at the results
from 24-hour blood pressure monitoring, we fit them in the recom-
mended criteria. So if they’re hypertensive, they’re hypertensive.
The criteria are very clear.
But the pressure is not always dramatically high. So a mean
blood pressure of 135 mm Hg would bring you into a category
of hypertensive patient. I don’t know personally how relevant
that is. The other point is, we’ve reviewed 305 patients who
were not screened with 24-hour blood pressure monitoring.
What we’ve seen is that, with casual blood pressure measurements,
the patients who had reintervention were no longer hypertensive in
the long term.
Dr Gaynor. I don’t think we know. But all I’m saying is I don’t
think the data fully prove or support your hypothesis that the hy-
pertension is the result of failure of growth of the proximal arch.
Because we don’t know where the level of reobstruction is, there
is not a good correlation of reobstruction with the hypertension.
And even your ambulatory pressures did not correlate with left
ventricular hypertrophy, so we don’t know what the significance of
the hypertension is, which suggests this is relatively mild. And,
again, I’m concerned we may be going down sort of the wrong
path of looking at the anatomic characteristics of the arch that
may just be intrinsic to these patients and there may be other ther-
apies that are necessary.
Dr John Foker (Minneapolis, Minn). I would like to reinforce
the points that Bill has just made. If you have a very tight coarcta-
tion, lower body flow is provided with the ductus, arch flowwill be
reduced, and the transverse arch is going to be small. We have be-
gun looking at our>300 rotated subclavian flap repairs, many of
them in patients who are<1 month of age. Although our review
is not complete, the reinterventions—by balloon dilation, usu-
ally—were for problems around the coarctation site. We are find-
ing the arch grew reliably when increased flow through it was
established.
Dr d’Udekem. I commend you for your excellent results, and I
apologize for what I will say. I know that in the literature the peo-
ple say that the aortic arch grew, but you have to be realistic. And I
invite you to review the literature on the topic; it’s really appalling.
I mean, it’s possible that the arch really grows, but please give me
data. The only reports that are published specify a ratio between
the transverse arch and the descending aorta, and we found that
to be unreliable when you look carefully at the patients because
there is enormous variability in the size of the aorta. There is 1 pa-
per in the literature that has looked at the z score of the transverse
arch, and that’s only a single paper, and it does not describe at
which level of the proximal or the distal transverse arch the mea-
surements were taken. So I’m ready to believe all of you that the
proximal transverse arch does grow after coarctation repair, but
please give me the evidence. I’m sorry.diovascular Surgery c Volume 144, Number 5 1117
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sary and I provided none. We believe that with a very tight coarc-
tation, there is no reason the transverse arch should be any larger
than the subclavian artery. So far, in the review of our patients,
relief of obstruction produced catch-up growth, indicating the hy-
poplasia is flow related rather than intrinsic. But, careful measure-
ments are necessary. Nevertheless, as the preceding discussion
brought out, there are other important factors including the nature
of the vessel walls that will affect the outcome.
Dr Emile Bacha (New York, NY). But on the opposite side there
are also tight coarctations with normal-size aortic arches, so it’s
not always the case that if you have a tight coarctation you get a hy-
poplastic arch.
Dr Foker. I’m overstating it to make the point. But vessels grow
with flow. I mean, they really do.
Dr Bacha. I think 1 nice point that I learned from this study is
that the 24-hour monitoring will detect some patients who don’t
know they’re hypertensive, which is something that I really never
realized.
Dr Joseph J. Amato (Chicago, Ill). I have just completed an ex-
tensive review on coarctation of the aorta. To begin with, first of
all, the Waldhausen procedure has been shown to have tremendous
amount of residual coarctations. A recent chapter in Pediatric Car-
diac Surgery by Dr Backer shows the results of 8 institutions using
this method to have as high as 23% to 42% of recoarctation. Also,
the possibility of left arm ischemia, and loss of length and function
of the left arm are possible. I really believe that this operation
should not be used.
The second comment is to ask you to define the types of end-to-
end or extended surgical methods that you chose. Was this the1118 The Journal of Thoracic and Cardiovascular SurAmato extended end-to-end or the Elliott or Zannini types? With
these later types, you can extend the anastomosis quite a way
across the arch.
Also, there are measurements of the size of the aortic arch.
These are usually divided into 3 segments and can be defined as
hypoplastic either when less than the size of the innominate artery
in millimeters or less than the bodyweight in kilograms plus 1mm.
I agree that looking at preoperative hypertension might have
been impossible because these were infants who did not have
time to develop hypertension. Thank you.
Dr d’Udekem. The majority of them were neonates. And it’s
old records.
Dr Amato.What about the size of the left ventricle? Was their
left ventricular hypertrophy massive, severe, small?
Dr d’Udekem. They were neonates and they were operated
more than 18 years ago. It’s very difficult to get these data.
Dr Stephen Langley (Portland, Ore).Melissa, congratulations.
It’s very difficult as a medical student to come and present at this
meeting. In fact, it can very difficult even if you’re not a medical
student to come and present here; so, congratulations.
One question for Yves: Has this study altered your practice?
And if so, how? And what are your current criteria for doing an
arch repair or a coarctation repair via a median sternotomy?
Dr d’Udekem. I’m a bit scared now, but thank you for asking
the question. Today in Melbourne, we look at the proximal trans-
verse arch because we’ve shown that the distal transverse arch can
be solved by an extended end-to-end repair and there is no question
about that. But if today you’re presenting in Melbourne with
a proximal transverse arch z score that is<2, you would have
an operation from the front and an end-to-side repair.gery c November 2012
